Sign in Subscribe
International cooperation

Hoth Therapeutics to Attend BIO International Convention in Boston, MA

Strategic Insights

— 1 min read

Hoth Therapeutics, Inc. (NASDAQ: HOTH) has announced that Robb Knie, Chief Executive Officer, will attend the BIO International Convention in Boston, MA, from June 16-19, 2025. The convention represents the largest and most comprehensive event for biotechnology, with 20,000 industry leaders from across the globe.

Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and groundbreaking treatments with a goal to improve patient quality of life. The company utilizes a patient-centric approach, collaborating and partnering with scientists, clinicians, and key opinion leaders to investigate therapeutics with immense potential to create breakthroughs and diversify treatment options.

Key Takeaways:

  • Hoth Therapeutics will be represented by Robb Knie, Chief Executive Officer, at the BIO International Convention in Boston, MA, from June 16-19, 2025.
  • The company is a clinical-stage biopharmaceutical company focused on developing innovative treatments with a patient-centric approach.
  • Hoth Therapeutics has partnered with scientists, clinicians, and key opinion leaders to investigate therapeutics with breakthrough potential.
  • The company's goal is to improve patient quality of life through the development of impactful and groundbreaking treatments.
  • The BIO International Convention is the largest and most comprehensive event for biotechnology, with 20,000 industry leaders from across the globe.
  • The event will provide Hoth Therapeutics with opportunities to collaborate and network with industry leaders and experts in the field of biotechnology.

Statistics:

  • 20,000 industry leaders from across the globe will attend the BIO International Convention in Boston, MA, from June 16-19, 2025.
  • Hoth Therapeutics is a clinical-stage biopharmaceutical company with a focus on developing innovative treatments.
  • The company has a patient-centric approach, collaborating with scientists, clinicians, and key opinion leaders to develop therapeutics with breakthrough potential.
  • The BIO International Convention is the largest event for biotechnology, with 20,000 attendees from across the globe.

Sources:

  • Hoth Therapeutics, Inc. Press Release (June 16, 2025)
  • BIO International Convention website
  • Hoth Therapeutics, Inc. SEC filings (Form 10-K)

Read more